The rise in omicron variant infections has prompted concerns about the prospect of a third wave of coronavirus and the efficacy of currently available vaccinations. Omicron, which is thought to be more transmissible than the preceding version, is more likely to infect a large number of people in a shorter amount of time. When opposed to the Delta version, the symptoms of this variant are milder. However, researchers believe that due to its high rate of transmissibility, it will soon become the prevalent form worldwide.
Delta and Omicron are both mutant forms of the COVID-19 original strain, which was discovered in China in 2019. Delta was first discovered in India in 2020, prompting the country’s second coronavirus outbreak, which claimed millions of lives, while cases of the omicron form were first detected in South Africa. Both types of symptoms are distinct from one another. Fatigue, joint pain, a cold, and headaches are four prevalent omicron symptoms that differ from those of the Delta variety, according to experts. Apart from that, the Omicron lacked the normal indications of Delta, such as loss of smell and taste.
Omicron, according to an AIIMS expert, may not produce dyspnea like Delta or another prior COVID-19 type since it multiplies in the neck rather than the respiratory system. As a result, he believes that the impact of omicron infection on the lungs will be minor. It indicates that, unlike the Delta illness, which resulted in a high number of people being hospitalized and suffering from pneumonia, the new variation may not have the same effect.
